330 related articles for article (PubMed ID: 25256924)
1. BRCA1 germline mutations may be associated with reduced ovarian reserve.
Wang ET; Pisarska MD; Bresee C; Chen YD; Lester J; Afshar Y; Alexander C; Karlan BY
Fertil Steril; 2014 Dec; 102(6):1723-8. PubMed ID: 25256924
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone serum concentrations of women with germline BRCA1 or BRCA2 mutations.
Phillips KA; Collins IM; Milne RL; McLachlan SA; Friedlander M; Hickey M; Stern C; Hopper JL; Fisher R; Kannemeyer G; Picken S; Smith CD; Kelsey TW; Anderson RA;
Hum Reprod; 2016 May; 31(5):1126-32. PubMed ID: 27094481
[TBL] [Abstract][Full Text] [Related]
3. Assessment of ovarian reserve and reproductive outcomes in
Ponce J; Fernandez-Gonzalez S; Calvo I; Climent M; Peñafiel J; Feliubadaló L; Teulé A; Lázaro C; Brunet JM; Candás-Estébanez B; Durán Retamal M
Int J Gynecol Cancer; 2020 Jan; 30(1):83-88. PubMed ID: 31780568
[TBL] [Abstract][Full Text] [Related]
4. Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency.
Oktay KH; Bedoschi G; Goldfarb SB; Taylan E; Titus S; Palomaki GE; Cigler T; Robson M; Dickler MN
Fertil Steril; 2020 Jun; 113(6):1251-1260.e1. PubMed ID: 32331767
[TBL] [Abstract][Full Text] [Related]
5. Antimüllerian hormone levels are lower in BRCA2 mutation carriers.
Johnson L; Sammel MD; Domchek S; Schanne A; Prewitt M; Gracia C
Fertil Steril; 2017 May; 107(5):1256-1265.e6. PubMed ID: 28476184
[TBL] [Abstract][Full Text] [Related]
6. BRCA carriers have similar reproductive potential at baseline to noncarriers: comparisons in cancer and cancer-free cohorts undergoing fertility preservation.
Gunnala V; Fields J; Irani M; D'Angelo D; Xu K; Schattman G; Rosenwaks Z
Fertil Steril; 2019 Feb; 111(2):363-371. PubMed ID: 30527950
[TBL] [Abstract][Full Text] [Related]
7. Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
van Tilborg TC; Derks-Smeets IA; Bos AM; Oosterwijk JC; van Golde RJ; de Die-Smulders CE; van der Kolk LE; van Zelst-Stams WA; Velthuizen ME; Hoek A; Eijkemans MJ; Laven JS; Ausems MG; Broekmans FJ
Hum Reprod; 2016 Nov; 31(11):2651-2659. PubMed ID: 27907901
[TBL] [Abstract][Full Text] [Related]
8. Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.
Winship AL; Willson C; Hansen KR; Hutt KJ; Hickey M
BMJ Open; 2019 Nov; 9(11):e033810. PubMed ID: 31772111
[TBL] [Abstract][Full Text] [Related]
9. The Impact of BRCA1- and BRCA2 Mutations on Ovarian Reserve Status.
C E DK; C VTT; J C EM; G W M LE; Irene H; Mariette G; J T VGR; Willem V; D LK; J M BF; M E BA
Reprod Sci; 2023 Jan; 30(1):270-282. PubMed ID: 35705781
[TBL] [Abstract][Full Text] [Related]
10. Association of BRCA1 Mutations with Impaired Ovarian Reserve: Connection Between Infertility and Breast/Ovarian Cancer Risk.
Giordano S; Garrett-Mayer E; Mittal N; Smith K; Shulman L; Passaglia C; Gradishar W; Pavone ME
J Adolesc Young Adult Oncol; 2016 Dec; 5(4):337-343. PubMed ID: 27513691
[TBL] [Abstract][Full Text] [Related]
11. BRCA1/2 gene mutations do not affect the capacity of oocytes from breast cancer candidates for fertility preservation to mature in vitro.
Grynberg M; Dagher Hayeck B; Papanikolaou EG; Sifer C; Sermondade N; Sonigo C
Hum Reprod; 2019 Feb; 34(2):374-379. PubMed ID: 30561604
[TBL] [Abstract][Full Text] [Related]
12. Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.
Denis-Laroque L; Drouet Y; Plotton I; Chopin N; Bonadona V; Lornage J; Salle B; Lasset C; Rousset-Jablonski C
Breast; 2021 Oct; 59():239-247. PubMed ID: 34304065
[TBL] [Abstract][Full Text] [Related]
13. BRCA1/2 genes mutations, ovarian reserve and female reproductive outcomes: a systematic review of the literature.
Merlino L; Chiné A; Galli C; Piccioni MG
Minerva Ginecol; 2020 Oct; 72(5):339-348. PubMed ID: 32744451
[TBL] [Abstract][Full Text] [Related]
14. Impact of BRCA1 and BRCA2 mutations on ovarian reserve and fertility preservation outcomes in young women with breast cancer.
Porcu E; Cillo GM; Cipriani L; Sacilotto F; Notarangelo L; Damiano G; Dirodi M; Roncarati I
J Assist Reprod Genet; 2020 Mar; 37(3):709-715. PubMed ID: 31872386
[TBL] [Abstract][Full Text] [Related]
15. Association of Germline BRCA Pathogenic Variants With Diminished Ovarian Reserve: A Meta-Analysis of Individual Patient-Level Data.
Turan V; Lambertini M; Lee DY; Wang E; Clatot F; Karlan BY; Demeestere I; Bang H; Oktay K
J Clin Oncol; 2021 Jun; 39(18):2016-2024. PubMed ID: 33891474
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 mutation carriers have a lower number of mature oocytes after ovarian stimulation for IVF/PGD.
Derks-Smeets IAP; van Tilborg TC; van Montfoort A; Smits L; Torrance HL; Meijer-Hoogeveen M; Broekmans F; Dreesen JCFM; Paulussen ADC; Tjan-Heijnen VCG; Homminga I; van den Berg MMJ; Ausems MGEM; de Rycke M; de Die-Smulders CEM; Verpoest W; van Golde R
J Assist Reprod Genet; 2017 Nov; 34(11):1475-1482. PubMed ID: 28831696
[TBL] [Abstract][Full Text] [Related]
17. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
[TBL] [Abstract][Full Text] [Related]
18. Effects of BRCA gene mutation on female reproductive potential: A systematic review.
Hu KL; Wang S; Ye X; Zhang D
Maturitas; 2020 Jul; 137():11-17. PubMed ID: 32498931
[TBL] [Abstract][Full Text] [Related]
19. Association of
Son KA; Lee DY; Choi D
Front Endocrinol (Lausanne); 2019; 10():235. PubMed ID: 31031710
[No Abstract] [Full Text] [Related]
20. Ovarian Aging in Women With BRCA Germline Mutations.
Lin W; Titus S; Moy F; Ginsburg ES; Oktay K
J Clin Endocrinol Metab; 2017 Oct; 102(10):3839-3847. PubMed ID: 28938488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
